Imaging the serotonin 1A receptor using[11C]WAY100635 in healthy controls and major depression

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1615, 2013, Pages

  Hesselgrave, Natalie ^a   Parsey, Ramin V ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Depression; Genotype; Positron emission tomography; Serotonin 1A

Indexed keywords

ABNORMALITY; BRAIN; DISEASE TREATMENT; FUNCTIONAL ROLE; GENETIC ANALYSIS; GENOTYPE; HEALTH STATUS; HORMONE; LIGAND; MENTAL HEALTH; POLYMORPHISM; PUBLIC HEALTH; TOMOGRAPHY; TRACER;

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; DESMETHYL WAY 100635; DESMETHYL-WAY 100635; LIGAND; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR;

CASE CONTROL STUDY; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; HUMAN; MAJOR DEPRESSION; METHODOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROMOTER REGION; PROTEIN BINDING; REVIEW;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; HUMANS; LIGANDS; PIPERAZINES; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 84883890829     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0004     Document Type: Article

References (55)

1. Berger M, Gray JA, Roth BL. 2009 The expanded biology of serotonin. Annu. Rev. Med. 60, 355-366. (doi:10.1146/annurev.med.60.042307.110802)
2. Sullivan GM, Oquendo MA, Simpson N, Van Heertum RL, Mann JJ, Parsey RV. 2005 Brain serotonin 1A receptor binding in major depression is related to psychic and somatic anxiety. Biol. Psychiat. 58, 947-954. (doi:10.1016/j.biopsych.2005.05.006)
3. Jovanovic H, Perski A, Berglund H, Savic I. 2011 Chronic stress is linked to 5-HT(1A) receptor changes and functional disintegration of the limbic networks. NeuroImage 55, 1178-1188. (doi:10. 1016/j.neuroimage.2010.12.060)
4. Nikolaus S, Antke C, Muller HW. 2009 In vivo imaging of synaptic function in the central nervous system. II. Mental and affective disorders. Behav.Brain Res. 204, 32-66. (doi:10.1016/j.bbr.2009.06.009)
5. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005 Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiat. 62, 617-627. (doi:10.1001/archpsyc.62.6.617)
6. Hasin DS, Goodwin RD, Stinson FS, Grant BF. 2005 Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiat. 62, 1097-1106. (doi:10.1001/archpsyc.62.10.1097)
7. Pincus HA, Pettit AR. 2001 The societal costs of chronic major depression. J. Clin. Psychiat. 62, 5-9.
8. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. 2003 Cost of lost productive work time among US workers with depression. J. Am. Med. Assoc. 289, 3135-3144. (doi:10.1001/jama.289.23.3135)
9. Bender A, Farvolden P. 2008 Depression and the workplace: a progress report. Curr. Psychiat. Rep. 10, 73-79. (doi:10.1007/s11920-008-0013-6)
10. WHO. 2011 Depression. Geneva, Switzerland: World Health Organization. See http://www.who.int/mental_health/management/depression/definition/en/ (updated on 18 August 2011; accessed on 15 November 2011).
11. Naudon L, El Yacoubi M, Vaugeois JM, Leroux- Nicollet I, Costentin J. 2002 A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness. Brain Res. 936, 68-75. (doi:10.1016/S0006-8993(02)02548-9)
12. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH. 1998 Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl Acad. Sci. USA 95, 15049-15054. (doi:10.1073/pnas.95.25.15049)
13. Haddjeri N, Blier P, de Montigny C. 1998 Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J. Neurosci. 18, 10150-10156.
14. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ. 2001 Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25, 892-903. (doi:10. 1016/S0893-133X(01)00310-4)
15. 11 C]WAY-100635. Eur. J. Pharmacol. 301, R5-R7.(doi:10.1016/0014-2999(96)00079-9)
16. Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ, Parsey RV. 2009 Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34, 2275-2284. (doi:10.1038/npp.2009.54)
17. Innis RB et al. 2007 Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27, 1533-1539.(doi:10.1038/sj.jcbfm.9600493)
18. Slifstein M, Parsey RV, Laruelle M. 2000 Derivation of [11C]WAY-100635 binding parameters withreference tissue models: effect of violations of model assumptions. Nucl. Med. Biol. 27, 487-492. (doi:10.1016/S0969-8051(00)00117-7)
19. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA. 1992 Quantitation of carbon-11-abeled raclopride in rat striatum using positron emission tomography. Synapse 12, 47-54. (doi:10. 1002/syn.890120106)
20. Lammertsma AA, Hume SP. 1996 Simplified reference tissue model for PET receptor studies. NeuroImage 4, 153-158. (doi:10.1006/nimg.1996. 0066)
21. Parsey RV et al. 2000 Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans:comparison of arterial and reference tisssue input functions. J. Cereb. Blood Flow Metab. 20, 1111-1133. (doi:10.1097/00004647-200007000-00011)
22. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, Mann JJ. 2005 Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J. Cereb. Blood Flow Metab. 25, 785-793. (doi:10.1038/sj.jcbfm.9600072)
23. Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Nagren K, Salminen JK, Hiet-al J. 2008 Decreased brain serotonin 5-HT1Areceptor availability in medication-naive patients with major depressive disorder: an in-vivo imagingstudy using PET and [carbonyl-11C]WAY-100635. Int. J. Neuropsychopharmacol. 11, 465-476.(doi:10.1017/s1461145707008140)
24. Hirvonen J, Kajander J, Allonen T, Oikonen V, Nagren K, Hiet-al J. 2007 Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635: considerations on the validity of cerebellum as a reference region. J. Cereb. Blood Flow Metab. 27, 185-195. (doi:10.1038/sj.jcbfm.9600326)
25. Cidis Meltzer C et al. 2001 Gender-specific aging effects on the serotonin 1A receptor. Brain Res. 895, 9-17. (doi:10.1016/S0006-8993(00)03211-X)
26. Arango V, Underwood MD, Gubbi AV, Mann JJ. 1995 Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688, 121-133. (doi:10.1016/0006-8993(95)00523-S)
27. Moses-Kolko EL et al. 2011 Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology 36, 2729-2740. (doi:10.1038/npp.2011.163)
28. Cleare AJ, Bond AJ. 2000 Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology (Berl.) 148, 344-349. (doi:10. 1007/s002130050061)
29. Cleare AJ, Bond AJ. 2000 Experimental evidence that the aggressive effect of tryptophan depletion is mediated via the 5-HT1A receptor. Psychopharmacology (Berl.) 147, 439-441. (doi:10.1007/s002130050014)
30. 11)C]WAY- 100635 binding to 5-HT1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuro Image 15, 620-632.(doi:10.1006/nimg.2001.0984)
31. 11]WAY-100635. Brain Res. 954, 173-182. (doi:10.1016/S0006- 8993(02)03243-2)
32. Parsey RV et al. 2010 Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol. Psychiat. 68, 170-178. (doi:10.1016/j.biopsych.2010.03.023)
33. Ogden RT, Tarpey T. 2006 Estimation in regression models with externally estimated parameters. Biostatistics 7, 115-129. (doi:10.1093/biostatistics/kxi044)
34. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. 1999 PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiat. 46, 1375-1387. (doi:10.1016/S0006-3223(99)00189-4)
35. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ. 2000 Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY- 100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiat. 57, 174-180. (doi:10.1001/archpsyc.57.2.174)
36. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ. 2006 Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiat. 59, 106-113. (doi:10.1016/j.biopsych.2005.06.016)
37. Lemonde S et al. 2003 Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23, 8788-8799.
38. Parsey RV, Belanger MJ, Sullivan GM, Simpson NR, Stabin MG, Van Heertum R, Mann JJ. 2005 Biodistribution and radiation dosimetry of 11C-WAY100, 635 in humans. J. Nucl. Med. 46,614-619.
39. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C. 2007 Serotonin-1A receptor imaging in recurrent depression: replicationand literature review. Nucl. Med. Biol. 34, 865-877. (doi:10.1016/j.nucmedbio.2007.06.008)
40. Martinez D et al. 2001 Differential occupancy of somatodendritic and postsynaptic 5HT1A receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans. Neuropsychopharmacology 24, 209-229. (doi:10.1016/S0893-133X(00)00187-1)
41. O'Reilly KC, Trent S, Bailey SJ, Lane MA. 2007 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Exp. Biol. Med. 232, 1195-1203. (doi:10.3181/0703-RM-83)
42. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C. 1998 Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann. N Y Acad. Sci. 861, 204-216. (doi:10.1111/j.1749-6632.1998.tb10192.x)
43. Gardier AM, Malagie I, Trillat AC, Jacquot C, Artigas F. 1996 Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10, 16-27. (doi:10.1111/j.1472-8206.1996.tb00145.x)
44. Rush AJ et al. 2006 Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiat. 163, 1905-1917. (doi:10.1176/appi.ajp.163.11.1905)
45. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. 2006 Higher 5-HT1A receptor binding potential during a major depressiveepisode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31, 1745-1749. (doi:10.1038/sj.npp.1300992)
46. Le Francois B, Czesak M, Steubl D, Albert PR. 2008 Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55, 977-985. (doi:10.1016/j. neuropharm.2008.06.046)
47. Richardson-Jones JW et al. 2010 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40-52. (doi:10.1016/j.neuron.2009.12.003)
48. Spindelegger C et al. 2009 Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders. Mol. Psychiat. 14, 1040-1050. (doi:10.1038/mp.2008.35)
49. Gray NA, Milak MS, Delorenzo C, Ogden RT, Huang Y, Mann JJ, Parsey RV In press. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biol. Psychiat.
50. Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JS, Majo VJ, Mann JJ, Parsey RV. 2010 In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer. J. Nucl. Med. 51, 1892-1900. (doi:10.2967/jnumed.110.076257)
51. Ogden RT, Zanderigo F, Choy S, Mann JJ, Parsey RV. 2010 Simultaneous estimation of input functions: an empirical study. J. Cereb. Blood Flow Metab. 30, 816-826. (doi:10.1038/jcbfm.2009.245)
52. Zanderigo F, Ogden RT, Mann JJ, Parsey RV. 2010 A voxel-based clustering approach for the automatic selection of testing regions in the simultaneous estimation of input functions in PET. NeuroImage 52, S176. (doi:10.1016/j.neuroimage. 2010.04.143)
53. American Psychiatric Association. 2000 Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edn Washington, DC: American Psychiatric Association.
54. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. 2010 Research domain criteria (RDoC): toward a new classificationframework for research on mental disorders. Am. J. Psychiat. 167, 748-751. (doi:10.1176/appi.ajp.2010.09091379)
55. Sanislow CA, Pine DS, Quinn KJ, Kozak MJ, Garvey MA, Heinssen RK, Wang PS, Cuthbert BN. 2010 Developing constructs for psychopathology research: research domain criteria. J. Abnorm. Psychol. 119, 631-639. (doi:10.1037/a0020909)